Clincosm LogoSign in Get a demo

nmo spectrum disorder

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NMO Spectrum Disorder, Spasticity, Muscle Trial in Boston (Nabiximols, Placebo)

Not yet recruiting
  • NMO Spectrum Disorder
  • Spasticity, Muscle
  • Boston, Massachusetts
    Massachusetts General Hospital
Aug 2, 2023

NMO Spectrum Disorder, Azathioprine Adverse Reaction Trial in Nanning (Azathioprine)

Completed
  • NMO Spectrum Disorder
  • Azathioprine Adverse Reaction
  • Nanning, Guangxi, China
    Qingmeng Huang
Jun 8, 2023

NMO Spectrum Disorder Trial (Acceptance and Commitment Therapy)

Not yet recruiting
  • NMO Spectrum Disorder
  • Acceptance and Commitment Therapy
  • (no location specified)
Apr 21, 2023

NMO Spectrum Disorder Trial in Tianjin (Baricitinib)

Not yet recruiting
  • NMO Spectrum Disorder
  • Tianjin, Tianjin, China
    Tianjin Medical University General Hospital
Mar 18, 2023

Antibody-mediated Rejection, NMO Spectrum Disorder, TTP Trial in Iowa City

Recruiting
  • Antibody-mediated Rejection
  • +3 more
    • Iowa City, Iowa
      DeGowin blood Center
    Oct 31, 2022

    Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder, NMO Spectrum Disorder Trial in Tianjin (Daratumumab, Placebo)

    Recruiting
    • Neuromyelitis Optica
    • +2 more
    • Tianjin, Tianjin, China
      Tianjin Medical University General Hospital
    Oct 19, 2022

    Multiple Sclerosis, NMO Spectrum Disorder Trial in Hangzhou (LP-168 tablet, LP-168 Placebo tablet)

    Recruiting
    • Multiple Sclerosis
    • NMO Spectrum Disorder
    • LP-168 tablet
    • LP-168 Placebo tablet
    • Hangzhou, Zhejiang, China
      The Second Affiliated Hospital Zhejiang University School of Med
    Jun 26, 2022

    Sensitivity and Specificity of TSA-CBA for Autoantibodies

    Recruiting
    • NMO Spectrum Disorder
    • +6 more
    • CBA-TSA
    • Beijing, Beijing, China
      Beijing Tiantan Hospital
    Jun 8, 2022

    NMO Spectrum Disorder Trial in Beijing, Taiyuan, Tianjin (B001 injection, Placebo)

    Recruiting
    • NMO Spectrum Disorder
    • B001 injection
    • Placebo
    • Beijing, Beijing, China
    • +2 more
    Apr 19, 2022

    Neuromyelitis Optica, NMO Spectrum Disorder Trial in Rochester

    Recruiting
    • Neuromyelitis Optica
    • NMO Spectrum Disorder
      • Rochester, Minnesota
        Mayo Clinic
      Mar 11, 2022

      NMO Spectrum Disorder Trial in Guangzhou (HBM9161 Injection)

      Completed
      • NMO Spectrum Disorder
      • HBM9161 Injection
      • Guangzhou, Guangdong, China
        Nanfang Hospital
      Jan 9, 2022

      CNS Inflammatory Demyelinating Diseases

      Not yet recruiting
      • Multiple Sclerosis
      • +4 more
      • Intravenous steroid
      • (no location specified)
      Nov 29, 2021

      Imaging Evaluation of Central Nervous Autoimmune Diseases

      Not yet recruiting
      • MS (Multiple Sclerosis)
      • NMO Spectrum Disorder
      • MRI
      • (no location specified)
      Mar 28, 2021

      COVID-19 in Patients With MS or NMO

      Unknown status
      • Multiple Sclerosis
      • +2 more
      • Evaluation of the epidemiological characteristics of coronavirus infection (SARS-CoV-2)
      • Paris, France
        Hôpital Pitié Salpétrière
      Apr 28, 2020

      Neuromyelitis Optica, Devic's Disease, NMO Spectrum Disorder Trial in Chicago (Rituximab, Cyclophosphamide, Mesna)

      Withdrawn
      • Neuromyelitis Optica
      • +2 more
      • Chicago, Illinois
      • +1 more
      Nov 18, 2019